Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisa Schrader Echeverri

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Chemical Communications (Cambridge, England)|February 25, 2025
The time course of <i>in vivo</i> cellular responses to LNPsDavid Loughrey, Kalina Paunovska, Elisa Schrader Echeverri, et al.
Advanced Drug Delivery Reviews|May 11, 2026
High-dose biologics and bioconjugates delivery: Integrating molecular optimization with device design and routes of administrationNaresh K Budhavaram, Kevin Harrison Duffy, Abraham H Abouzeid, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 5, 2022
Computational modeling of corneal and scleral collagen photocrosslinkingBrandon G Gerberich, Amy J Wood-Yang, Afsane Radmand, et al.
Nano Letters|June 7, 2022
Universal Barcoding Predicts <i>In Vivo</i> ApoE-Independent Lipid Nanoparticle DeliveryAlejandro J Da Silva Sanchez, Curtis Dobrowolski, Ana Cristian, et al.
Small (Weinheim an Der Bergstrasse, Germany)|August 31, 2023
Multivalent Targeting of the Asialoglycoprotein Receptor by Virus-Like ParticlesRobert Hincapie, Sonia Bhattacharya, Michael M Baksh, et al.
Advanced Healthcare Materials|February 6, 2024
Substituting Poly(ethylene glycol) Lipids with Poly(2-ethyl-2-oxazoline) Lipids Improves Lipid Nanoparticle Repeat DosingAlejandro J Da Silva Sanchez, David Loughrey, Elisa Schrader Echeverri, et al.
Nano Letters|December 15, 2022
The Extent to Which Lipid Nanoparticles Require Apolipoprotein E and Low-Density Lipoprotein Receptor for Delivery Changes with Ionizable Lipid StructureKalina Paunovska, Alejandro J Da Silva Sanchez, Melissa P Lokugamage, et al.
Nature Biotechnology|June 26, 2025
Lipid nanoparticle screening in nonhuman primates with minimal loss of lifeRyan Zenhausern, Bora Jang, Elisa Schrader Echeverri, et al.
Thrombosis Research|March 10, 2024
Impact of allele-selective silencing of von Willebrand factor in mice based on a single nucleotide allelic difference in von Willebrand factorYvonne K Jongejan, Noa A Linthorst, Elisa Schrader Echeverri, et al.
Nature Biomedical Engineering|October 7, 2021
Optimization of lipid nanoparticles for the delivery of nebulized therapeutic mRNA to the lungsMelissa P Lokugamage, Daryll Vanover, Jared Beyersdorf, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Chemical Communications (Cambridge, England)|February 25, 2025
The time course of <i>in vivo</i> cellular responses to LNPsDavid Loughrey, Kalina Paunovska, Elisa Schrader Echeverri, et al.
Advanced Drug Delivery Reviews|May 11, 2026
High-dose biologics and bioconjugates delivery: Integrating molecular optimization with device design and routes of administrationNaresh K Budhavaram, Kevin Harrison Duffy, Abraham H Abouzeid, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 5, 2022
Computational modeling of corneal and scleral collagen photocrosslinkingBrandon G Gerberich, Amy J Wood-Yang, Afsane Radmand, et al.
Nano Letters|June 7, 2022
Universal Barcoding Predicts <i>In Vivo</i> ApoE-Independent Lipid Nanoparticle DeliveryAlejandro J Da Silva Sanchez, Curtis Dobrowolski, Ana Cristian, et al.
Small (Weinheim an Der Bergstrasse, Germany)|August 31, 2023
Multivalent Targeting of the Asialoglycoprotein Receptor by Virus-Like ParticlesRobert Hincapie, Sonia Bhattacharya, Michael M Baksh, et al.
Advanced Healthcare Materials|February 6, 2024
Substituting Poly(ethylene glycol) Lipids with Poly(2-ethyl-2-oxazoline) Lipids Improves Lipid Nanoparticle Repeat DosingAlejandro J Da Silva Sanchez, David Loughrey, Elisa Schrader Echeverri, et al.
Nano Letters|December 15, 2022
The Extent to Which Lipid Nanoparticles Require Apolipoprotein E and Low-Density Lipoprotein Receptor for Delivery Changes with Ionizable Lipid StructureKalina Paunovska, Alejandro J Da Silva Sanchez, Melissa P Lokugamage, et al.
Nature Biotechnology|June 26, 2025
Lipid nanoparticle screening in nonhuman primates with minimal loss of lifeRyan Zenhausern, Bora Jang, Elisa Schrader Echeverri, et al.
Thrombosis Research|March 10, 2024
Impact of allele-selective silencing of von Willebrand factor in mice based on a single nucleotide allelic difference in von Willebrand factorYvonne K Jongejan, Noa A Linthorst, Elisa Schrader Echeverri, et al.
Nature Biomedical Engineering|October 7, 2021
Optimization of lipid nanoparticles for the delivery of nebulized therapeutic mRNA to the lungsMelissa P Lokugamage, Daryll Vanover, Jared Beyersdorf, et al.
Pageof 3